Abstract
Peptide infusions of peptides the corticotropin releasing factor family, including urocortin 2, stresscopin, and urocortin 3 (UCn3), have favorable acute effects in clinical heart failure (HF), but their short half-lives make them unsuitable for chronic therapy. This study asked whether UCn3 gene transfer, which provides sustained elevation of plasma UCn3 levels, increases the function of the failing heart. HF was induced by transmural left ventricular (LV) cryoinjury in mice. LV function was assessed 3 weeks later by echocardiography. Those with ejection fractions (EF)
Original language | English |
---|---|
Pages (from-to) | 10-20 |
Number of pages | 11 |
Journal | Human Gene Therapy |
Volume | 30 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2019 |
Keywords
- gene therapy
- heart failure with reduced EF
- SERCA2a
- AAV8
- ADENOASSOCIATED VIRUS VECTORS
- MYOCARDIAL-INFARCTION
- FAILURE
- PHARMACOKINETICS
- DYSFUNCTION
- EXPRESSION
- MUSCLE
- MOUSE